PUBLIC RELEASE DATE: <\/p>\n
10-Apr-2014 <\/p>\n
Contact: Lee-Ann Donegan leeann.donegan@uphs.upenn.edu<\/a> 215-349-5660 University of Pennsylvania School of Medicine<\/p>\n (PHILADELPHIA) Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys. Folliculin's absence or mutated state has a cascading effect that leads to deteriorated lung integrity and an impairment of lung function, as reported in their findings in the current issue of Cell Reports. <\/p>\n \"We discovered that without normal FLCN the alveolar epithelial cells (AEC) in these patients' lungs began to die, leading to holes in the lungs that grow as increasing numbers of cells disappear. These holes can fill with air and burst, causing the lungs to collapse,\" says Vera Krymskaya, PhD, MBA, associate professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, and researcher in the Airway Biology Initiative of the department of Pulmonary, Allergy and Critical Care. <\/p>\n Between 80 and 100 percent of patients with BHD will develop multiple holes or cysts in the lung. <\/p>\n Healthy human alveoli, the terminal ends of the respiratory tree, are lined with type I and type II alveolar epithelial cells (AECs), a renewable population of progenitors in these distal airspaces. AECs are known to maintain pulmonary alveolar homeostasis by regulating gas exchange and fluid transport in the lungs. <\/p>\n Previous studies have shown that there might be some crosstalk between FLCN and the master energy sensor AMP-activated protein kinase (AMPK). AMPK maintains epithelial cell to cell interactions and is essential for epithelial cell survival. It is regulated through LKB1, a tumor suppressor gene associated with 30 percent of lung cancers. E-cadherin, the \"zipper\" molecule that connects epithelial cells, directs LKB1 to cell junctions and its loss impairs LKB1-mediated AMPK activation. This implies that a loss of or mutation in FLCN can trigger a reaction that can impair AMPK activation, epithelial cell to cell interaction and structure, and as a result, promotes cell death. <\/p>\n Penn researchers set out to examine this hypothesis to determine how and why this occurs. <\/p>\n Krymskaya and her team tested both deleted FLCN in mouse lung type II alveolar epithelial cells and mutated FLCN that lacked normal function in both humans with BHD and mouse epithelial cell systems, and compared them with normal human and mouse control cells. <\/p>\n <\/p>\n Go here to see the original: <\/p>\n Penn study finds mechanism that regulates lung function in disease Birt-Hogg-Dube syndrome<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" PUBLIC RELEASE DATE: 10-Apr-2014 Contact: Lee-Ann Donegan leeann.donegan@uphs.upenn.edu<\/a> 215-349-5660 University of Pennsylvania School of Medicine (PHILADELPHIA) Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys. Folliculin's absence or mutated state has a cascading effect that leads to deteriorated lung integrity and an impairment of lung function, as reported in their findings in the current issue of Cell Reports. \"We discovered that without normal FLCN the alveolar epithelial cells (AEC) in these patients' lungs began to die, leading to holes in the lungs that grow as increasing numbers of cells disappear Continue reading